Category: Blood Clots

Who needs to wear an SCD and How long Should SCDs Be Worn?: An Interview with Dr. Amy Campbell on Preventing Blood Clot

By Michael Wong, JD (Founder & Executive Director, Physician-Patient Alliance for Health & Safety)

CDC estimates that almost one million Americans suffer from venous thromboembolism (VTE), also known as blood clots. VTE is a term that is comprised of two medical conditions deep vein thrombosis (DVT), which is a blood clot in one or more of the deep veins in the body, usually in the legs, and pulmonary embolism (PE), which is a blood clot in a pulmonary artery in the lungs. 

According to the CDC:

  • As many as 100,000 people die of blood clots each year.
  • PE is a leading cause of death in a woman during pregnancy or just after having a baby.
  • Blood clots are a leading cause of death in people with cancer after cancer itself.

Continue reading “Who needs to wear an SCD and How long Should SCDs Be Worn?: An Interview with Dr. Amy Campbell on Preventing Blood Clot”

Misinformation can be Catastrophic for Cardiovascular Patients

By Andrea Baer (Executive Director, The Mended Hearts, Inc.) and Michael Wong, JD (Founder/Executive Director, Physician-Patient Alliance for Health & Safety)

Making sure you have correct medical information—rather than misinformation (i.e., false information)—could save you from being admitted to the hospital or even save your life.

There is a lot of medical information and education on cardiovascular disease, particularly on the internet. But with that comes the problem of misinformation. Finding trustworthy information can be challenging, and relying upon wrong information can have health ramifications. Just because something is on the internet does not mean it’s medically true.

Misinformation

To read the complete article, please go to Patient Safety & Quality Healthcare by clicking here.

CVS Caremark’s Decision Putting Eliquis Back on Its Formulary Benefits Patients

CVS Caremark’s Decision Putting Eliquis Back on Its Formulary Benefits Patients

Editor’s note: Recently, CVS Caremark reversed its decision to exclude Eliquis (apixaban) from its formulary. This is an update to previous posts on this issue – “CVS Caremark Formulary Exclusion of Eliquis is a Patient Safety Risk,” “Non-Medication Switching is a Patient Safety Issue,” and “How a Patient Battled with CVS Caremark and Won

By Michael Wong, JD (Founder & Executive Director, Physician-Patient Alliance for Health & Safety)

CVS Caremark Puts Patients First By Putting Eliquis Back on Formulary

CVS Caremark has put patients first by putting Eliquis® (apixaban) back on its formulary. By doing so, they have stayed true to their motto – “Your health is our priority. At CVS Caremark, each and every one of us is dedicated to helping you on your path to better health.”

Now, I can’t say the same thing about its decision at the end of 2021, but I’ll let you be the judge of that. In its original decision, CVS Caremark (part of CVS Health) decided to exclude Eliquis from the CVS Caremark Preferred Drug List. Eliquis is “indicated to reduce the risk of stroke and systemic embolism in patients with NVAF. Eliquis is indicated for the treatment of DVT [deep vein thrombosis] and PE [pulmonary embolism], and to reduce the risk of recurrent DVT and PE following initial therapy.” Eliquis is a Factor Xa inhibitor and is a Direct Oral Anticoagulant (DOAC). 

Continue reading “CVS Caremark’s Decision Putting Eliquis Back on Its Formulary Benefits Patients”

3 Myths About Strokes: Don’t Let These Misconceptions About Strokes Affect Your Health

3 Myths About Strokes: Don’t Let These Misconceptions About Strokes Affect Your Health

By Michael Wong, JD (Founder/Executive Director, Physician-Patient Alliance for Health & Safety)

Stroke Myths You Should be Aware of for National Stroke Awareness Month

This month of May is National Stroke Awareness Month. In thinking about National Stroke Awareness Month, I immediately thought of my friend, Mark McEwen, who most people know as a reporter for CBS:

Continue reading “3 Myths About Strokes: Don’t Let These Misconceptions About Strokes Affect Your Health”

A Misdiagnosis of Blood Clots Can Be Costly – Particularly During COVID-19

A Misdiagnosis of Blood Clots Can Be Costly – Particularly During COVID-19

By Michael Wong, JD (Executive Director, Physician-Patient Alliance for Health & Safety)

In the early months of the COVID-19 epidemic, abnormal clotting was found in COVID-19 patients. As Bin Cao, MD, who is with the National Clinical Research Center for Respiratory Diseases in Beijing, described wide-spread clots in COVID-19 patients in a March 19, 2020 webinar cosponsored by the Chinese Cardiovascular Association and the American College of Cardiology – he found “clots in the small vessels of all organs, not only the lungs but also including the heart, the liver, and the kidney.” 

Continue reading “A Misdiagnosis of Blood Clots Can Be Costly – Particularly During COVID-19”

3 Tools for Better Management of Non-Valvular Atrial Fibrillation

3 Tools for Better Management of Non-Valvular Atrial Fibrillation

By Jane Nelson Worel RN, MS, ANP-BC, FAHA (Clinical Education, Preventive Cardiovascular Nurses Association)

Helping patients with Non-Valvular Atrial Fibrillation (NVAF) involves implementing guidelines-based strategies to effectively balance the reduced risk of deadly or debilitating strokes with the risk of bleeding—along with factors such as patient age and overall health. To help clinicians navigate the challenges faced by patients with Atrial Fibrillation (AFib)—the most common arrhythmia seen in clinical practice—the Preventive Cardiovascular Nurses Association (PCNA) has developed a trio of educational and reference tools for providers that will increase knowledge and directly impact clinical practice.

Continue reading “3 Tools for Better Management of Non-Valvular Atrial Fibrillation”

3 Studies About the COVID Pandemic Everyone Needs to Know

3 Studies About the COVID Pandemic Everyone Needs to Know

Because the COVID pandemic has presented us with unprecedented circumstances (probably only matched in current times by the 1918 Flu Pandemic, which occurred before most of our lives), our understanding of COVID is continually evolving and improving based on new research and data. Learning from new research and applying that knowledge to our lives and how we care for patients is essential

For this week, here are 3 studies that everyone needs to know about during this COVID pandemic:

Continue reading “3 Studies About the COVID Pandemic Everyone Needs to Know”